Ion channels 3D structures: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 231: | Line 231: | ||
**[[2yks]], [[3uq4]], [[3uq5]], [[3uq7]], [[4twh]], [[5hej]], [[5heo]], [[5heu]], [[5hew]] – EchELIC (mutant)<br /> | **[[2yks]], [[3uq4]], [[3uq5]], [[3uq7]], [[4twh]], [[5hej]], [[5heo]], [[5heu]], [[5hew]] – EchELIC (mutant)<br /> | ||
**[[6v03]], [[6v0b]], [[8d63]], [[8d64]], [[8d65]] - EchELIC – Cryo EM<br /> | **[[6v03]], [[6v0b]], [[8d63]], [[8d64]], [[8d65]] - EchELIC – Cryo EM<br /> | ||
**[[8d66]], [[8d67]], [[ | **[[8d66]], [[8d67]], [[8vuw]] – EchELIC3 (mutant) – Cryo EM<br /> | ||
**[[3rqw]] - EchELIC + acetylcholine<br /> | **[[3rqw]] - EchELIC + acetylcholine<br /> | ||
**[[5sxu]] - EchELIC + bromoethanol<br /> | **[[5sxu]] - EchELIC + bromoethanol<br /> | ||
Revision as of 10:56, 7 February 2024
3D structures of ion channels
Updated on 07-February-2024
- 7kuh – mVDAC – electron crystallography
- 6g9o, 6g9l, 6g8z, 6o00, 6nzz, 6nzw, 7m17, 7m19 – mVDAC1 subunit LRRC8A – Cryo EM
- 8b40 – mVDAC1 subunit LRRC8C – Cryo EM
- 8ben – mVDAC1 subunit LRRC8C LRR domain – Cryo EM
- 8b42, 8dr8, 8dra, 8dre, 8drk, 8drn, 8dro, 8drq, 8ds3, 8ds9, 8dsa, 8dxn – mVDAC1 subunit LRRC8A + LRRC8C – Cryo EM
- 8f74, 8f75, 8f77, 8f79, 8f7b, 8f7d, 8f7e, 8f7j – mVDAC1 subunit LRRC8A + LRRC8C (mutant) – Cryo EM
- 8b41 – mVDAC1 subunit LRRC8A + LRRC8C + nanobody – Cryo EM
- 7p5v, 7p5w, 7p5y, 7p60, 7p6k – mVDAC1 subunit LRRC8A + nanobody – Cryo EM
- 6fnw – mVDAC1 subunit LRRC8A C terminal
- 4bum – zeVDAC2
- 7en0 – VDAC1 – Brachypodium distachyon – Cryo EM
- 7w6k – ALMT – soy bean – Cryo EM
- 7wnq – AtSLAC1 – Cryo EM
- 7kuh – mVDAC – electron crystallography
- Ligand-gated ion channel
- 5osa, 5osb – mGLIC + GABAAR
- 5osc – mGLIC + GABAAR + drug
- 2vl0, 3rqu, 2yn6 – EchELIC – Erwinia chrysanthemi
- 2yks, 3uq4, 3uq5, 3uq7, 4twh, 5hej, 5heo, 5heu, 5hew – EchELIC (mutant)
- 6v03, 6v0b, 8d63, 8d64, 8d65 - EchELIC – Cryo EM
- 8d66, 8d67, 8vuw – EchELIC3 (mutant) – Cryo EM
- 3rqw - EchELIC + acetylcholine
- 5sxu - EchELIC + bromoethanol
- 4twd, 4twf - EchELIC (mutant) + memantine derivative
- 3zkr - EchELIC + anesthetic
- 2yoe - EchELIC + drug + GABA
- 4a97, 4a98, 5lid, 5lg3 – EchELIC + drug
- 5sxv – EchELIC + inhibitor
- 4yeu – EchELIC + GLIC
- 6hk0 – DcELIC (mutant) – Dickeya chrysanthemi
- 6hjx, 6hjy, 6ssi, 6ssp – DcELIC + nanobody
- 6fl9, 6fli, 6fvq, 6fvr, 6fvs - ELIC – vent tica
- 3eam, 3ehz, 4hfi, 4il4, 4ilc, 4npp, 4npq, 4qh1, 4qh5, 4qh4, 6f7a, 6f16, 4zzc, 6hzw – GvGLIC - Gloeobacter violaceus
- 6zgd, 6zgj, 6zgk – GvGLIC – Cryo EM
- 6hk0 – DcELIC (mutant) – Dickeya chrysanthemi
- 6hjx, 6hjy, 6ssi, 6ssp – DcELIC + nanobody
- 6fl9, 6fli, 6fvq, 6fvr, 6fvs - ELIC – vent tica
- 3eam, 3ehz, 4hfi, 4il4, 4ilc, 4npp, 4npq, 4qh1, 4qh5, 4qh4, 6f7a, 6f16, 4zzc, 6hzw – GvGLIC – Gloeobacter violaceusbr />
- 3lsv, 3tls, 3tlt, 3tlu, 3tlv, 3tlw, 3uu3, 3uu4, 3uu5, 3uu6, 3uu8, 3uub, 3ei0, 4hfb, 4il9, 4ila, 4ilb, 4ire, 4lmj, 4lmk, 4lml, 5hcj, 5hcm, 5heg, 5heh, 5iux, 5v6o, 5v6n, 5nkj, 5njy, 5mzt, 5mzr, 5mzq, 4zzb, 6hy5, 6hy9, 6hya, 6hyr, 6hyv, 6hyw, 6hyx, 6hyz, 6hz0, 6hz1, 6hz3, 6emx, 6f0i, 6f0j, 6f0m, 6f0n, 6f0r, 6f0u, 6f0v, 6f0z, 6f10, 6f11, 6f12, 6f13, 6f15, 6f16, 6i08 – GvGLIC (mutant)
- 3igq – GvGLIC N-terminal
- 2xq3, 2xq4, 2xq5, 2xq6, 2xq7, 2xqa, 2xq8 – GvGLIC+inhibitor
- 2xq9 – GvGLIC (mutant)+inhibitor
- 3p4w, 3p50, 4f8h, 4hfh – GvGLIC + general anaesthetic
- 4hfd, 5mvn, 5mvm, 5mur, 5muo – GvGLIC (mutant) + general anaesthetic
- 4hfc, 4hfe - GvGLIC (mutant) + alcohol
- 5j0z - GvGLIC + choline derivative
- 5l47, 5l4e, 5l4h - GvGLIC + barbiturate
- 6hj3, 6hjb, 6hji, 6hja, 6hjz, 6hpp - GvGLIC + carboxylate
- 6v4a, 6v4s, 7q3g - DeELIC – Desulfofustis
- 7q3h – DeELIC – Cryo EM
- 5osa, 5osb – mGLIC + GABAAR
- Cyclic Nucleotide-Gated channel
- 7lg1 – hCNGA1 (mutant) – Cryo EM
- 7lft – hCNGA1 + cGMP – Cryo EM
- 7lfw, 7lfx, 7lfy – hCNGA1 (mutant) + cGMP – Cryo EM
- 7rh9, 7rhl – hCNGA1 + CNGB1 – Cryo EM
- 7rhg, 7rhh, 7rhi, 7rhj, 7rhk – hCNGA1 + CNGB1 + cGMP – Cryo EM
- 8bx7 – bCNGA1 + CNGB1 + cGMP – Cryo EM
- 7rhs – hCNGA3 + CNGB3 – Cryo EM
- 3swf - bCNGC CLZ domain
- 2zd9, 3beh - MlCNGC - Mesorhizobium loti
- 4chv, 4chw – MlCNGC – Cryo EM
- 2ptm - CNGC C-terminal - Strongylocentratus purpuratus
- 2kxl, 1vp6 - MlCNGC ligand-binding domain
- 3co2, 4muv, 3clp, 1u12 - MlCNGC ligand-binding domain (mutant)
- 3cl1, 2k0g - MlCNGC ligand-binding domain + cyclic nucleotide
- 5h3o – CeCNGC – Cryo EM
- 6wej, 6wek, 6wel – CeCNGC + cGMP – Cryo EM
- 6cju, 6vxz, 6vy0 – StCNGC + cAMP – Spitochaeta thermophila - Cryo EM
- 6cjq – StCNGC - Cryo EM
- 6cjt – StCNGC + cGMP - Cryo EM
- 7lg1 – hCNGA1 (mutant) – Cryo EM
- Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel
- 5u6o, 5u6p, 6uqf, 6uqg – hCNGC 1 – Cryo EM
- 2mpf – hCNGC 2 ligand-binding domain - NMR
- 3swy – hCNGC 3 CLZ domain
- 6gyn – hCNGC 4 – Cryo EM
- 6gyo – hCNGC 4 + cAMP – Cryo EM
- 3otf – hCNGC 4 ligand-binding domain
- 2mng – hCNGC 4 ligand-binding domain - NMR
- 4hbn – hCNGC 4 ligand-binding domain (mutant)
- 4kl1 – hCNGC 4 C terminal + nucleotide
- 4nvp – hCNGC 4 ligand-binding domain + 7-CH-cAMP
- 7nmn, 7np3 – rCNGC 4 – Cryo EM
- 7np4 – rCNGC 4 + cAMP – Cryo EM
- 3etq, 3ffq, 3u0z, 3u10, 3u11 - mCNGC C-terminal
- 1q3e, 1q43, 1q5o - mCNGC 2 fragment + nucleotide
- 2q0a - mCNGC 2 C-terminal (mutant)
- 3bpz - mCNGC 2 ligand-binding domain
- 5khg, 5khh, 5khi, 5khj, 5khk – mCNGC 2 ligand-binding domain + nucleotide
- 5u6o, 5u6p, 6uqf, 6uqg – hCNGC 1 – Cryo EM
- Acid sensing ion channel
- 6l6i, 6l6n, 6l6p – hASC
- 7cfs – hASC – Cryo EM
- 7cft – hASC + toxin – Cryo EM
- 7rnn – hASC + nanobody – Cryo EM
- 3ij4, 2qts, 3s3w, 4nyk, 3ij4, 6ave, 5wku, 5wkv, 5wky, 5wkx, 6cmc – cASC – chicken
- 7lie – cASC thumb domain 291-367
- 6vtk, 6vtl – cASC – Cryo EM
- 3s3x, 4fz0, 4fz1 – cASC + psalmotoxin
- 4ntw, 4ntx, 4nty - cASC + neurotoxin + basic phospholipase A2
- 6x9h – cASC + modulator
- 6l6i, 6l6n, 6l6p – hASC
- ATP-Gated P2X channel (AGC) or P2X purinoceptor
- 5svj, 5svs, 5svt – hAGC P2X3
- 5yve – hAGC P2X3 + modulator
- 5svq, 5svr – hAGC P2X3 + antagonist
- 5svm, 5svp – hAGC P2X3 + agonist
- 5svk, 5svl, 6ah4, 6ah5 – hAGC P2X3 + ATP
- 5u1l – paAGC P2X - panda
- 5u1u, 5u1v, 5u1w, 5u1x, 5u1y – paAGC P2X + antagonist
- 5u2h – paAGC P2X + antagonist + ATP
- 6u9v – raAGC P2X7 – Cryo EM
- 6u9w – raAGC P2X7 + ATP – Cryo EM
- 2rup – raAGC P2X4 head domain 111-167 – NMR
- 5xw6 – cAGC P2X7 + antagonist
- 3h9v, 3i5d – zeAGC P2X4
- 4dw0 – zeAGC P2X4 (mutant)
- 4dw1 – zeAGC P2X4 + ATP
- 5wzy – zeAGC P2X4 + CTP
- 5svj, 5svs, 5svt – hAGC P2X3
- Proton channel or matrix protein 2
- 2kj1, 2l0j - IVproton channel – Influenza virus - NMR
- 2kih, 2kwx – IVproton channel (mutant)
- 3bkd, 4qkm, 4qkl, 4qkc, 4qk7, 3lbw, 5ttc, 5um1, 5joo - IVproton channel transmembrane domain
- 1nyj, 1mp6, 2kad, 6pvr, 6pvt - IVproton channel transmembrane domain - NMR
- 5c02, 4rwc, 4rwb, 2kih, 6mjh - IVproton channel transmembrane domain (mutant)
- 2n70 - IVproton channel transmembrane domain (mutant) - NMR
- 6bkk, 6bkl, 6bmz, 6boc, 6us8, 6us9 - IVproton channel transmembrane domain + drug
- 2h95, 2kqt - IVproton channel transmembrane domain + drug - NMR
- 2ly0 - IVproton channel transmembrane domain (mutant) + drug - NMR
- 2rlf - IVproton channel + inhibitor - NMR
- 3c9j, 6oug - IVproton channel transmembrane domain + inhibitor
- 6nv1 - IVproton channel transmembrane domain (mutant) + inhibitor
- 8bdz, 8ber - proton channel M2 – Hepatitis virus – Cryo EM
- 2kj1, 2l0j - IVproton channel – Influenza virus - NMR
- Voltage-gated hydrogen channel (VGHC)
- Transient receptor potential cation channel, vanilloid subfamily (TRPV)
- TRPV1 or capsaicin receptor
- 7lp9, 7lpa, 7lpc, 7lpd, 8gf8, 8gf9, 8gfa – hTRPV1 – Cryo EM
- 6l93 – hTRPV1 ankyrin repeat domain 101-365
- 2nyj – hTRPV1 ankyrin repeat domain + ATP
- 7lqy, 7lqz – sTRPV1 – squirrel - Cryo EM
- 7lr0 – sTRPV1 + capsaicin - Cryo EM
- 3j5p, 3j5r, 3j9j, 5irz – rTRPV1 – Cryo EM
- 5is0 – rTRPV1+ capsaicin derivative – Cryo EM
- 5irx – rTRPV1+ DKTX – Cryo EM
- 3j5q – rTRPV1+ toxin – Cryo EM
- 2pnn – rTRPV1 ankyrin repeat domain
- 7l2h, 7l2i, 7l2j, 7l2k, 7l2l, 7l2m, 7l2n, 7l2o, 7l2p, 7l2r, 7l2s, 7l2t, 7l2u, 7l2v, 7l2w, 7l2x, 7lpb, 7lpe, 7mz5, 7mz6, 7mz7, 7mz9, 7mza, 7mzb, 7mzc, 7mzd, 7mze, 7rqu, 7rqv, 7rqw, 7rqx, 7rqy, 7rqz – raTRPV1 + drug – Cryo EM
- 7lp9, 7lpa, 7lpc, 7lpd, 8gf8, 8gf9, 8gfa – hTRPV1 – Cryo EM
- TRPV2
- 5hi9 – hTRPV2 – Cryo EM
- 2f37, 4n5q – hTRPV2 ankyrin repeat domain 69-367
- 2eta, 2etb, 2etc – rTRPV2 ankyrin repeat domain - rat
- 6bo4, 6bo5, 6u84, 6u86 – rTRPV2 – Cryo EM
- 6wkn, 7n0m, 7n0n, 7t37, 7t38, 7zjh, 8slx, 8sly – raTRPV2 + cannabidiol – Cryo EM
- 6u88, 6u8a – rTRPV2 + cannabidiol – Cryo EM
- 6bwm – raTRPV2 – rabbit
- 5an8, 6oo3, 6oo4, 6oo5, 6oo7 – raTRPV2 – Cryo EM
- 6bwj – raTRPV2 (mutant) + resiniferatoxin
- 6b5v – raTRPV2 + inhibitor – Cryo EM
- 7xeu – mTRPV2 – Cryo EM
- 7xer, 7xew – mTRPV2 (mutant) – Cryo EM
- 7xem – mTRPV2 + cholesterol – Cryo EM
- 7xeo, 7xev, 7yep – mTRPV2 + ligand – Cryo EM
- 5hi9 – hTRPV2 – Cryo EM
- TRPV3
- 6mho, 6mhs, 6mhv, 6mhw, 6mhx, 6uw4 – hTRPV3 – Cryo EM
- 6ot2, 6uw6, 6uw8, 6uw9 – hTRPV3 (mutant) – Cryo EM
- 6ot5 – hTRPV3 (mutant) + inhibitor – Cryo EM
- 7xj0 – hTRPV3 + drug – Cryo EM
- 6dvw, 6dvy, 6lgp, 6pvl, 6pvm, 7mik – mTRPV3 – Cryo EM
- 7mij, 7mik, 7mil, 7mim, 7min, 7mio, 7ras, 7rau, 7ugg – mTRPV3 + drug – Cryo EM
- 6dvz, 6pvn, 6pvp, 6pvo, 6pvq – mTRPV3 (mutant) – Cryo EM
- 4n5q – mTRPV3 ankyrin repeat domain 118-367
- 6mho, 6mhs, 6mhv, 6mhw, 6mhx, 6uw4 – hTRPV3 – Cryo EM
- TRPV4
- TRPV5
- TRPV6
- 6bo8, 6bo9, 7k4a, 8fob – hTRPV6 – Cryo EM
- 6boa, 6d7s, 6d7t – hTRPV6 (mutant) – Cryo EM
- 7k4b, 7k4c, 7k4d, 7k4e, 7k4f, 7s8c, 8foa – hTRPV6 + inhibitor – Cryo EM
- 7s88, 7s89, 7s8b – hTRPV6 + blocker – Cryo EM
- 5iwk, 5iwp, 5iwr, 5iwt, 5wo6, 5wo7, 5wo8, 5wo9, 5woa, 6d7o, 6d7v – rTRPV6
- 6d7p, 6d7q, 6d7x – rTRPV6 (mutant)
- 6bob – rTRPV6 – Cryo EM
- 6e2f, 6e2g – rTRPV6 + calmodulin – Cryo EM
- 2rfa – mTRPV6 ankyrin repeat domain 44-265
- 7d2k – raTRPV6 + inhibitor – Cryo EM
- 6bo8, 6bo9, 7k4a, 8fob – hTRPV6 – Cryo EM
- Glycerol facilitator